ArticleFrontiers in pharmacology2022

Efficacy and Adverse Events of PD-1 Inhibitors in Patients With Advanced Urothelial Carcinoma From a Real-World Experience.

Fengze Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.